Shah Tilak, Lippman Robert, Kohli Divyanshoo, Mutha Pritesh, Solomon Sanjeev, Zfass Alvin
Hunter Holmes McGuire VA Medical Center - Medicine (Gastroenterology), Richmond, Virginia, USA.
Virginia Commonwealth University Medical Center - Medicine (Gastroenterology), Richmond, Virginia, USA.
Endosc Int Open. 2018 Apr;6(4):E414-E420. doi: 10.1055/s-0043-124868. Epub 2018 Mar 29.
For surveillance of Barrett's esophagus (BE), the current standard of random 4-quadrant biopsies misses 10 - 50 % of esophageal neoplasms, and does not permit real-time decision-making. Probe-based confocal laser endomicroscopy (pCLE) permits real-time in vivo histologic assessment of esophageal mucosa during upper endoscopy. Prospective studies comparing the accuracy of pCLE to 4-quadrant biopsies in routine clinical practice are lacking.
Consecutive patients with BE underwent high definition white light and narrow-band imaging followed by pCLE and targeted biopsy or mucosal resection. Four-quadrant biopsies were obtained during the same session. Baseline variables, real-time pCLE interpretation, and histology results were prospectively recorded. Blinded expert review of pCLE sequences and histology specimens was performed. A sample size of 64 patients was calculated a priori based on 3 % estimated prevalence of high grade dysplasia (HGD) or cancer.
In total, 66 patients were included in the study. The prevalence of HGD or cancer was 4.55 %. Both real-time and blinded pCLE correctly identified all cases of cancer. For the primary outcome, real-time pCLE was 98 % specific but only 67 % sensitive for HGD/cancer compared to non-blinded pathologist interpretation. For HGD and cancer, inter-observer agreement was substantial between real-time and blinded endomicroscopists (kappa = 0.6). pCLE identified dysplasia in 75 % of cases where both blinded and unblinded pathology interpretation was low grade dysplasia.
pCLE demonstrates high specificity for detecting dysplasia and cancer, but lower sensitivity may limit its utility in routine BE surveillance. pCLE may have a role in confirming LGD in real-time before eradication therapy.
对于巴雷特食管(BE)的监测,当前随机四象限活检的标准会漏诊10%-50%的食管肿瘤,且不允许进行实时决策。基于探头的共聚焦激光内镜检查(pCLE)可在上消化道内镜检查期间对食管黏膜进行实时体内组织学评估。缺乏在常规临床实践中比较pCLE与四象限活检准确性的前瞻性研究。
连续的BE患者先接受高清白光和窄带成像,然后进行pCLE以及靶向活检或黏膜切除术。在同一次检查中获取四象限活检样本。前瞻性记录基线变量、实时pCLE解读和组织学结果。对pCLE序列和组织学标本进行盲法专家评审。基于估计的高级别异型增生(HGD)或癌症患病率3%,事先计算出64例患者的样本量。
该研究共纳入66例患者。HGD或癌症的患病率为4.55%。实时和盲法pCLE均正确识别了所有癌症病例。对于主要结局,与非盲法病理学家的解读相比,实时pCLE对HGD/癌症的特异性为98%,但敏感性仅为67%。对于HGD和癌症,实时和盲法内镜检查者之间的观察者间一致性较高(kappa=0.6)。在盲法和非盲法病理解读均为低级别异型增生的病例中,pCLE识别出异型增生的比例为75%。
pCLE在检测异型增生和癌症方面具有较高的特异性,但较低的敏感性可能会限制其在BE常规监测中的应用。pCLE可能在根除治疗前实时确认低级别异型增生方面发挥作用。